Investigation Into Fungal Meningitis Outbreak

On October 4, 2012, the Center for Disease Control announced an outbreak of fungal meningitis had been linked to tainted steroid injections produced by the New England Compounding Center. The Energy and Commerce Committee, on a bipartisan basis, quickly initiated an investigation, seeking briefings and documents from the Food and Drug Administration, the Centers for Diseases Control and Prevention, and the Massachusetts Board of Registration in Pharmacy. The investigation into the circumstances of the drug contamination continues.

This page contains information related to the investigation, and will be updated regularly as new information comes to light.

As of April 13, more than 700 people have been sickened and 53 people have been killed by the outbreak.

Documents

  • To read the background memo for the 4/16/13 hearing click here.
  • To read the background memo for the 11/14/12 hearing click here.
  • To read the January 2006 Consent Agreement between Massachusetts Board of Pharmacy and NECC click here.
  • Click here to read the preliminary staff report on "FDA's Oversight of NECC and Ameridose: A History of Missed Opportunities?"

Hearing

News Reports

  • The TODAY Show Previews Committee's Hearing on Deadly Meningitis Outbreak. Watch here.
  • CBS Evenings News discusses the fungal meningitis outbreak. Watch here.

Letters